FibroGen: Q4 Earnings Snapshot
By AP News
Published - Feb 27, 2023, 04:30 PM ET
Last Updated - Jun 22, 2023, 07:18 PM EDT
SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — FibroGen Inc. (FGEN) on Monday reported a loss of $66.2 million in its fourth quarter.
The San Francisco-based company said it had a loss of 70 cents per share.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 95 cents per share.
The biotech drug developer posted revenue of $34.4 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $23.9 million.
